UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Antihypertensive Response to Ketanserin: Influence of Race and Weight

Journal of clinical pharmacology, 1988-11, Vol.28 (11), p.1017-1022

1988

Link zum Volltext

Verfügbarkeit prüfen

Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects

European journal of clinical pharmacology, 2011-05, Vol.67 (5), p.483-492

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

International journal of chronic obstructive pulmonary disease, 2013-01, Vol.8 (default), p.107-116

2013

Link zum Volltext

Verfügbarkeit prüfen

Disposition of 14C-eptifibatide after intravenous administration to healthy men

Clinical therapeutics, 1998-03, Vol.20 (2), p.307-323

1998

Link zum Volltext

Verfügbarkeit prüfen

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects

Drug metabolism and disposition, 2002-04, Vol.30 (4), p.430

2002

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Antacid and Cimetidine on the Oral Absorption of the Antifungal Agent SCH 39304

Journal of clinical pharmacology, 1990-07, Vol.30 (7), p.638-642

1990

Link zum Volltext

Verfügbarkeit prüfen

Effect of Food on the Oral Bioavailability of Isosorbide-5-Mononitrate Administered as an Extended-Release Tablet

Journal of clinical pharmacology, 1995-02, Vol.35 (2), p.151-158

1995

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Multiple Doses of Ketoconazole or Rifampin on the Single- and Multiple-Dose Pharmacokinetics of Vorapaxar

Journal of clinical pharmacology, 2013-05, Vol.53 (5), p.540-549

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of Ezetimibe on Cyclosporine Pharmacokinetics in Healthy Subjects

Journal of clinical pharmacology, 2006-03, Vol.46 (3), p.321-327

2006

Link zum Volltext

Verfügbarkeit prüfen

Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers

Clinical pharmacology and therapeutics, 1991-08, Vol.50 (1), p.181-191

1991

Link zum Volltext

Verfügbarkeit prüfen

Endopeptidase 24.11 Inhibition by SCH 42495 in Essential Hypertension

Hypertension (Dallas, Tex. 1979), 1993-07, Vol.22 (1), p.119-126

1993

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device

Clinical pharmacology in drug development, 2014-05, Vol.3 (3), p.222-228

2014

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects

Clinical pharmacology in drug development, 2014-05, Vol.3 (3), p.229-234

2014

Link zum Volltext

Verfügbarkeit prüfen

Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactions

Clinical pharmacokinetics, 2005-01, Vol.44 (5), p.467-494

2005

Link zum Volltext

Verfügbarkeit prüfen

Hypothalamic-Pituitary-Adrenal Axis Effects of Mometasone Furoate/Formoterol Fumarate vs Fluticasone Propionate/Salmeterol Administered Through Metered-Dose Inhaler

Chest, 2013-12, Vol.144 (6), p.1795-1802

2013

Link zum Volltext

Verfügbarkeit prüfen

Influence of Food on the Oral Bioavailability of Loratadine and Pseudoephedrine from Extended-Release Tablets in Healthy Volunteers

Journal of clinical pharmacology, 1996-10, Vol.36 (10), p.923-930

1996

Link zum Volltext

Verfügbarkeit prüfen

Interaction of Single-Dose Ezetimibe and Steady-State Cyclosporine in Renal Transplant Patients

Journal of clinical pharmacology, 2006-03, Vol.46 (3), p.328-336

2006

Link zum Volltext

Verfügbarkeit prüfen

Mometasone Furoate Has Minimal Effects on the Hypothalamic-Pituitary-Adrenal Axis When Delivered at High Doses

Chest, 2000-12, Vol.118 (6), p.1538-1546

2000

Link zum Volltext

Verfügbarkeit prüfen

Mometasone furoate nasal spray : A review of safety and systemic effects

Drug safety, 2007-01, Vol.30 (4), p.317-326

2007

Link zum Volltext

Verfügbarkeit prüfen

No differences in the pharmacodynamics and pharmacokinetics of the thrombin receptor antagonist vorapaxar between healthy Japanese and Caucasian subjects

European journal of clinical pharmacology, 2012-03, Vol.68 (3), p.291-300

2012

Link zum Volltext

Verfügbarkeit prüfen

Once-Daily Evening Dosing of Mometasone Furoate Administered via a Dry Powder Inhaler Does Not Adversely Affect the Hypothalamic-Pituitary-Adrenal Axis

Chest, 2010-01, Vol.137 (1), p.115-121

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin

British journal of clinical pharmacology, 2002-09, Vol.54 (3), p.309-319

2002

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention

Circulation (New York, N.Y.), 2001-07, Vol.104 (4), p.406-411

2001

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects

European journal of clinical pharmacology, 2012-03, Vol.68 (3), p.249-258

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease

European journal of clinical pharmacology, 2012-07, Vol.68 (7), p.1049-1056

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCurrent Medical Research And Opinion

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antihypertensive Response to Ketanserin: Influence of Race and Weight

Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

Disposition of 14C-eptifibatide after intravenous administration to healthy men

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects

The Effect of Antacid and Cimetidine on the Oral Absorption of the Antifungal Agent SCH 39304

Effect of Food on the Oral Bioavailability of Isosorbide-5-Mononitrate Administered as an Extended-Release Tablet

The Effect of Multiple Doses of Ketoconazole or Rifampin on the Single- and Multiple-Dose Pharmacokinetics of Vorapaxar

Effects of Ezetimibe on Cyclosporine Pharmacokinetics in Healthy Subjects

Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers

Endopeptidase 24.11 Inhibition by SCH 42495 in Essential Hypertension

Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device

An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects

Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactions

Hypothalamic-Pituitary-Adrenal Axis Effects of Mometasone Furoate/Formoterol Fumarate vs Fluticasone Propionate/Salmeterol Administered Through Metered-Dose Inhaler

Influence of Food on the Oral Bioavailability of Loratadine and Pseudoephedrine from Extended-Release Tablets in Healthy Volunteers

Interaction of Single-Dose Ezetimibe and Steady-State Cyclosporine in Renal Transplant Patients

Mometasone Furoate Has Minimal Effects on the Hypothalamic-Pituitary-Adrenal Axis When Delivered at High Doses

Mometasone furoate nasal spray : A review of safety and systemic effects

No differences in the pharmacodynamics and pharmacokinetics of the thrombin receptor antagonist vorapaxar between healthy Japanese and Caucasian subjects

Once-Daily Evening Dosing of Mometasone Furoate Administered via a Dry Powder Inhaler Does Not Adversely Affect the Hypothalamic-Pituitary-Adrenal Axis

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin

Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention

Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects

Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease

Aktive Filter

Suchergebnisse filtern